Similar articles

• Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.

  Oner E, Erturk M, Birant A, Kurtar Mansıroglu A, Akturk IF, Karakurt H, Yalcin AA, Uzun F, Somuncu MU, Yildirim A. Oner E, et al. Cardiol J. 2015;22(1):87-93. doi: 10.5603/CJ.a2014.0044. Epub 2014 May 20. Cardiol J. 2015. PMID: 24846511 Clinical Trial.
• Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.

  Branzi G, Malfatto G, Villani A, Ciambellotti F, Revera M, Giglio A, Rosa FD, Facchini M, Parati G. Branzi G, et al. J Cardiovasc Med (Hagerstown). 2010 Sep;11(9):662-8. doi: 10.2459/JCM.0b013e32833832f6. J Cardiovasc Med (Hagerstown). 2010. PMID: 20613551 Clinical Trial.
• Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.

  Parissis JT, Panou F, Farmakis D, Adamopoulos S, Filippatos G, Paraskevaidis I, Venetsanou K, Lekakis J, Kremastinos DT. Parissis JT, et al. Am J Cardiol. 2005 Aug 1;96(3):423-6. doi: 10.1016/j.amjcard.2005.03.092. Am J Cardiol. 2005. PMID: 16054474 Clinical Trial.
• [Levosimendan in heart failure].

  Scelsi L, Campana C, Ghio S, Monti L, Opasich C, De Feo S, Cobelli F, Orlandi M, Di Pasquale G, Tavazzi L. Scelsi L, et al. Recenti Prog Med. 2004 Jul-Aug;95(7-8):376-83. Recenti Prog Med. 2004. PMID: 15303549 Review. Italian.
• [LEVOSIMENDAN--THE FIRST 10 YEARS IN CLINICAL PRACTICE].

  Rybka MM, Lobacheva GV. Rybka MM, et al. Anesteziol Reanimatol. 2015 Sep-Oct;60(5):80-4. Anesteziol Reanimatol. 2015. PMID: 26852586 Review. Russian.